Ishita Drugs and Industries Limited (BOM:524400)
74.85
+0.86 (1.16%)
At close: Feb 12, 2026
BOM:524400 Revenue
Ishita Drugs and Industries had revenue of 31.36M INR in the quarter ending December 31, 2025, a decrease of -24.10%. This brings the company's revenue in the last twelve months to 161.68M, up 8.30% year-over-year. In the fiscal year ending March 31, 2025, Ishita Drugs and Industries had annual revenue of 149.97M, down -1.25%.
Revenue (ttm)
161.68M
Revenue Growth
+8.30%
P/S Ratio
1.34
Revenue / Employee
11.55M
Employees
14
Market Cap
217.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 149.97M | -1.90M | -1.25% |
| Mar 31, 2024 | 151.88M | 31.15M | 25.81% |
| Mar 31, 2023 | 120.72M | -20.18M | -14.32% |
| Mar 31, 2022 | 140.90M | 1.41M | 1.01% |
| Mar 31, 2021 | 139.49M | -8.83M | -5.95% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.20B |
| Resonance Specialties | 899.72M |
| Vasundhara Rasayans | 315.86M |
| Link Pharma Chem | 258.97M |
| Crestchem | 242.52M |
| Krebs Biochemicals & Industries | 230.23M |
| Accretion Nutraveda | 160.49M |